Document

audit fees

Audit Fees
2024 2025
Audit Fees (1) 400120 2002881
Audit Related Fees — —
Tax Fees — —
All Other Fees — —
Total 400120 2002881

ors and corporate governance

ORS AND CORPORATE GOVERNANCE
Name Class Age Position Director
Since
Current
Term
Expires
Expiration of
Term For
Which
Nominated
Nominees for Director
Niall Casey I 50 Director, Chief Intellectual Property Officer, & Co-Founder 2018 2026 2029
Philip (Phil) Young (1) I 86 Director 2020 2026 2029
Directors
Robert Mittendorff, M.D., M.B.A. (2)(3) II 49 Director 2022 2027
Kevin O’Boyle (1)(2) II 70 Director 2024 2027
Jonathan (Jon) D. Root, M.D., M.B.A. (3) II 66 Director 2020 2027
Michael (Mike) Cordonnier III 50 Chairman, Chief Executive Officer, President & Co-Founder 2018 2028
Kevin Sidow (1)(2)(3) III 68 Director 2020 2028

director compensation

Director Compensation
Name Fees Earned
or Paid in
Cash
($)(1)
Stock Awards
($)(2)
Option Awards
($)(3)
All Other
Compensation
($)
Total
($)
Robert Mittendorff, M.D. 28750 — — — 28750
Kevin O’Boyle 48750 259995 — — 308745
Jonathan (Jon) D. Root, M.D. 27500 259995 — — 287495
Kevin Sidow 61250 259995 20454 — 341699
Philip (Phil) Young 27500 259995 — — 287495
Niall Casey 507668 -4 — 625828 -5 14821 -6 1148317

in beneficial owners and m

IN BENEFICIAL OWNERS AND MANAGEMENT
Shares of Common Stock Beneficially Owned
Name of Beneficial Owner Number %
5% or Greater Stockholder
Entities affiliated with B Capital Group (1) 8321763 30.6%
Entities affiliated with U.S. Venture Partners (2) 5642073 20.7%
Named Executive Officers and Directors
Michael Cordonnier (3) 1506353 5.5%
Niall Casey (4) 987464 3.6%
Scott Durall (5) 100396 *
Leonard Greenstein (6) 265063 1.0%
Robert Mittendorff, M.D. — —
Kevin O’Boyle (7) 43209 *
Jonathan D. Root, M.D. (8) 466666 1.7%
Kevin Sidow (9) 119483 *
Philip Young (10) 88899 *
All executive officers and directors as a group (9 persons) (11) 3577533 12.9%

summary compensation

Summary Compensation
Name and Principal Position Year Salary ($)
(1)
Bonus
($)
Stock
Awards
($)(2)
Option
Awards
($)(3)
Non-Equity
Incentive Plan
Compensation
($)(4)
All Other
Compensation
($)(5)
Total
($)
Mike Cordonnier 2025 480822 — 353218 1510370 414709 30848 2789967
Chief Executive Officer,
President
and Co-Founder
2024 362583 — — — 144770 13340 520693
Leo
Greenstein
2025 377863 — — 517423 217271 6754 1119311
Chief Financial Officer
and Treasurer
2024 345000 — — — 138000 5386 488386
Scott Durall 2025 411260 — — 802741 283770 18501 1516272
Chief Commercial
Officer
2024 116311 — — 250218 50558 — 417087

No Title

Option Awards Stock Awards
Name Vesting
Commencement
Date
Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
Option
Exercise
Price ($)
Option
Expiration
Date
Number
of Shares
or Units
of Stock
That
Have Not
Vested
Market
Value of
Shares or
Units that
Have Not
Vested ($)
Equity
Incentive
Plan
Awards:
Number of
Unearned
Shares,
Units or
Other
Rights
That Have
Not Vested
(#)
Equity
Incentive
Plan
Awards:
Market or
Payout Value
of Unearned
Shares, Units
or Other
Rights That
Have Not
Vested ($)
Mike Cordonnier 12/15/2020 -1 358422 — 0.33 1/7/31 — — — —
12/15/24 -1 56239 168717 4.35 2/18/35 — — — —
07/22/25 -2 8928 133929 15 7/21/35 — — — —
— -3 — — — — — — 112478 1389103
Leo Greenstein 8/14/23 -1 — — 1.17 8/21/33 59737 737752 — —
8/14/23 -1 48809 34864 1.17 8/21/33 — — — —
7/22/25 -2 4464 66965 15 7/21/35 — — — —
Scott Durall 09/3/24 -1 28001 61605 2.23 11/12/34 — — — —
12/15/24 -1 33743 101230 4.35 2/18/35 — — — —
07/22/25 -2 4464 66965 15 7/21/35 — — — —

uance under equity compens

UANCE UNDER EQUITY COMPENSATION PLANS
Plan Category Number of securities
to be issued upon
exercise of outstanding
options, warrants
and rights
Weighted-average
exercise price of
outstanding
options, warrants
and rights (2)
Number of securities
remaining available
for future issuance
under equity
compensation plans
(excluding securities
reflected in column
(a))
(a) (b) (c)
Equity compensation plans approved by security holders 1027227 -1 14.77 2972287 -3
Equity compensation plans not approved by security holders 2306370 -4 2.54 —
Total 3333597 17.31 2972287

nd related person transact

ND RELATED PERSON TRANSACTIONS
Participants (1) Shares of Series C
Convertible
Preferred
Stock
Aggregate
Purchase
Price
Entities affiliated with B Capital Group (2) 4098390 43999998.33
Entities affiliated with U.S. Venture Partners (3) 1676613 17999997.41